Analysis of Treatment Response and Chest CT Characteristics for Patients Treated by EGFR-TKI in Relapse Advanced Lung Adenocarcinoma

Analysis of Treatment Response and Chest CT Characteristics for Patients Treated by EGFR-TKI in Relapse Advanced Lung Adenocarcinoma

Background and objective For previously treated recurrent non-small cell lung cancer, many studies have proven that inhibitors of the tyrosine kinase of epidermal growth factor receptor (EGFR-TKI), such as gefitinib and erlotinib can increase survival, especially in non-smoker adenocarcinoma. The ob...

Full description

Bibliographic Details
Main Authors: Shuchang CHEN, Jianfeng ZHOU, Xiaohong NING, Yuzhou WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2008-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Computed tomography
Antineoplastic agent
Epidermal growth factor receptor
Tyrosine kinase inhibitor
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.02.027&path%5B%5D=57

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.02.027&path%5B%5D=57

Similar Items